ArticleFrontiers in immunology2022

Intranasal administration of a single dose of MVA-based vaccine candidates against COVID-19 induced local and systemic immune responses and protects mice from a lethal SARS-CoV-2 infection.

Patricia Pérez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.